Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
DSP Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSuven Pharmaceuticals Limited10.24842489539302.4043
Domestic EquitiesSun Pharmaceutical Industries Limited10.12651875450298.8061
Domestic EquitiesCipla Limited8.54061790481252.0102
Domestic EquitiesIPCA Laboratories Limited7.36751603985217.3961
Domestic EquitiesGland Pharma Limited4.8450920673142.9621
Domestic EquitiesApollo Hospitals Enterprise Limited3.9951194767117.8847
Domestic EquitiesLaurus Labs Limited3.96262217884116.9268
Domestic EquitiesSai Life Sciences Limited3.73411597108110.1845
Domestic EquitiesAlembic Pharmaceuticals Limited3.58771423563105.8633
Domestic EquitiesVijaya Diagnostic Centre Limited3.1627101907293.3215
Domestic EquitiesKovai Medical Center and Hospital Limited3.008816515688.7813
Domestic EquitiesPfizer Limited2.754420064481.2759
Domestic EquitiesProcter & Gamble Health Limited2.707515870479.8924
Domestic EquitiesConcord Biotech Limited2.483348977473.2751
Domestic EquitiesIndoco Remedies Limited2.1530323347463.5281
Domestic EquitiesUnichem Laboratories Limited1.730084385851.0492
Domestic EquitiesNarayana Hrudayalaya Ltd.1.572332118146.3946
Domestic EquitiesICICI Lombard General Insurance Company Limited1.383424141340.8217
Domestic EquitiesEmcure Pharmaceuticals Limited1.140434277633.6503
Domestic EquitiesAarti Drugs Limited1.014785215529.9405
Domestic EquitiesAlkem Laboratories Limited0.58793733417.3461
Domestic EquitiesThyrocare Technologies Limited0.533722906415.7493
Domestic EquitiesLupin Limited0.51738014615.2650
Domestic EquitiesJupiter Life Line Hospitals Limited0.46949647813.8513
Domestic EquitiesMedplus Health Services Limited0.465219207813.7259
Domestic EquitiesLaxmi Dental Limited0.32242804019.5126
Total 82.4139 2431.8189
Cash & Cash Equivalents and Net AssetsTREPS / Reverse Repo Investments1.8972 55.9828
Cash & Cash Equivalents and Net AssetsNet Receivables/Payables-0.1691 -4.9899
Total 1.7281 50.9929
Overseas EquitiesGlobus Medical Inc6.3947268800188.6909
Overseas EquitiesIllumina Inc4.2159160400124.4004
Overseas EquitiesIntuitive Surgical Inc3.18611876894.0122
Overseas EquitiesAbbott Laboratories1.29173160038.1150
Overseas EquitiesGrail Inc0.099787332.9431
Total 15.1881 448.1616
Overseas Mutual Fund UnitsGlobal X Funds - Global X Genomics & Biotechnology ETF0.669824500019.7636
Total 0.6698 19.7636
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.